Abstract
Background: Retention and compliance are hurdles in many clinical trials designed for adolescents. Factors that may improve these issues in a challenging population may lead to increased data and power in much needed adolescent substance abuse research.
Methods: Within a large-scale smoking cessation study for adolescents, physician continuity (PC) was examined to determine its effect on retention, compliance, and cessation.
Results: In an analysis of 98 participants, participants with physician continuity throughout the study were more likely to attend more treatment visits and be medication compliant. It was also found that PC had no effect on participant smoking cessation.
Conclusions: It appears that PC may be one way to increase retention and compliance within an adolescent clinical trial, without interfering with the specific aim of the research study (in this case, smoking cessation).
Keywords: Adolescent research, substance use, compliance.
Adolescent Psychiatry
Title:Does Physician Continuity Within a Clinical Trial Increase Retention and Compliance Among Adolescent Smokers?
Volume: 3 Issue: 2
Author(s): A. Lee Lewis, Nathaniel Baker, Matthew Carpenter, Erin Klintworth and Kevin M. Gray
Affiliation:
Keywords: Adolescent research, substance use, compliance.
Abstract: Background: Retention and compliance are hurdles in many clinical trials designed for adolescents. Factors that may improve these issues in a challenging population may lead to increased data and power in much needed adolescent substance abuse research.
Methods: Within a large-scale smoking cessation study for adolescents, physician continuity (PC) was examined to determine its effect on retention, compliance, and cessation.
Results: In an analysis of 98 participants, participants with physician continuity throughout the study were more likely to attend more treatment visits and be medication compliant. It was also found that PC had no effect on participant smoking cessation.
Conclusions: It appears that PC may be one way to increase retention and compliance within an adolescent clinical trial, without interfering with the specific aim of the research study (in this case, smoking cessation).
Export Options
About this article
Cite this article as:
Lewis A. Lee, Baker Nathaniel, Carpenter Matthew, Klintworth Erin and M. Gray Kevin, Does Physician Continuity Within a Clinical Trial Increase Retention and Compliance Among Adolescent Smokers?, Adolescent Psychiatry 2013; 3 (2) . https://dx.doi.org/10.2174/2210676611303020011
DOI https://dx.doi.org/10.2174/2210676611303020011 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular Response to Hypericin-Induced Photodamage
Current Medicinal Chemistry Pharmacotherpy and Alzheimer’s Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach
Current Pharmaceutical Design Investigating the Molecular Basis for the Selective Inhibition of Aldehyde Dehydrogenase 2 by the Isoflavonoid Daidzin
CNS & Neurological Disorders - Drug Targets Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets
Current Pharmaceutical Design Gold Nanomaterials: From Preparation to Pharmaceutical Design and Application
Current Pharmaceutical Design Analgesic and Anti-Inflammatory Effects of Essential Oils of Vitex agnuscastus L. from South-West of Algeria
Current Bioactive Compounds Gene Electrotransfer to Skin; Review of Existing Literature and Clinical Perspectives
Current Gene Therapy Alzheimer's Disease: Emerging Trends in Small Molecule Therapies
Current Medicinal Chemistry Multidrug Resistance Associated Proteins as Determining Factors of Pharmacokinetics and Pharmacodynamics of Drugs
Current Drug Metabolism Meet Our Editorial Board Member
Current Neuropharmacology Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists
Mini-Reviews in Medicinal Chemistry In Silico Ligand-Receptor Docking of Potentially Selective Butyrylcholinesterase Inhibitors Structurally Related to the Marine Natural Product Debromoflustramine B
Medicinal Chemistry PLGA Nanoparticles and Polysorbate-80-Coated PLGA Nanoparticles Increase the In vitro Antioxidant Activity of Melatonin
Current Drug Delivery Alcohol Enhances HIV Infection of Cord Blood Monocyte-Derived Macrophages
Current HIV Research Exercise for the Overweight and Obese
Current Pharmaceutical Design The Neuroendocrine System as a Model to Evaluate Experimental Gene Therapy
Current Gene Therapy The Effects of Different Antioxidants on the Activity of Cerebrocortical MnSOD and Na,K-ATPase from post mortem Alzheimer’s Disease and Age-matched Normal Brains
Current Alzheimer Research Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Cannabinoids, Opioids and MDMA: Neuropsychological Interactions Related to Addiction
Current Drug Targets Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry